Skip to main content
. 2023 Jul 25;2023(7):CD015078. doi: 10.1002/14651858.CD015078

Comparison 3. Individuals with a confirmed diagnosis of SARS‐CoV‐2 infection and asymptomatic to mild disease.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 All‐cause mortality up to longest follow‐up (45 days) 2 4209 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.00 [0.45, 2.22]
3.2 Admission to hospital or death up to day 45 2 4209 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.79 [0.57, 1.10]
3.3 Thrombotic events 2 4209 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.37 [0.09, 1.46]
3.4 Serious adverse events 1 3881 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.00 [0.60, 1.64]